Uvavanyo lwe-Neuroimaging lweengxaki zokunyakaza | iCongress ka-2026
UMichele Matarazzo: [00:00:00] Molo, kwaye wamkelekile kwi-MDS Podcast, i-podcast esemthethweni ye-International Parkinson and Movement Disorder Society. NdinguMichele Matarazzo, kwaye namhlanje sirekhoda bukhoma sisuka eSeoul, apha kwi-International Congress. Sizama ukugqamisa izinto ezibaluleke kakhulu ezenzekileyo kwiinyanga ezili-12 ezidlulileyo kunye nangexesha lale ngqungquthela kwezinye iindawo ezincinci zeengxaki zentshukumo.
Namhlanje, ndinovuyo lokuba noCecilia Peralta, ongusekela-sihlalo we-Neuroimaging Study Group, ngoko ke siza kuthetha nge-neuroimaging. Kwaye uvela kwi-CEMIC eBuenos Aires, eArgentina. Kwaye siza kuthetha ngento eyenzekileyo kwiinyanga ezimbalwa ezidlulileyo kwi-neuroimaging.
Jonga umbhalo opheleleyo
Siza kuthetha nangeQela loPhando lweNeuroimaging. Ngoko ke okokuqala, enkosi ngokujoyina nam, Cecilia.
Cecilia Peralta: Cecilia Enkosi, Michele. Enkosi ngesimemo sokuba ndibe lapha namhlanje. Ndiyavuya kakhulu.
UMichele Matarazzo: Besithi unendima ebalulekileyo. Ungusekela-sihlalo weQela loFundo lweNeuroimaging [00:01:00]. Kwaye ukuze ndityhile oku, ndikwayinxalenye yeqela loFundo, ngoko ke ndinolwazi lwangaphakathi. Ndiyazi ukuba iqela loFundo lenza izinto ezininzi ezahlukeneyo.
Ngoko ke ungabelana nabaphulaphuli bethu ngezinto eziphambili ezenzekayo okanye ezenzekileyo kutshanje?
UCecilia Peralto: Sineqela elihle kakhulu, kwaye kunye noThilo van Eimeren, ongusihlalo, sisebenza nzima kakhulu kwaye kunye namanye amalungu eqela. Ndimele ndithi eli qela linamandla kakhulu kwaye lenza izinto ezintle kakhulu. Ndingathi sinobuchule kakhulu kwezinye izinto. Sinobuchule ekuhlanganiseni abantu ukuze babandakanyeke kumaphepha ophando kunye neeprojekthi zokubambisana. Sinobuchule ekubhaleni amaphepha kunye nokupapasha, kwaye ngandlela ithile ndicinga ukuba sinobuchule ekucebiseni. Loo nto ibaluleke kakhulu ngakumbi kumalungu aselula, kuba lawo malungu aselula akhangela amathuba okujoyina iqela ukuze abhale iphepha, enze uphando. Ngoko ke lelo liqela elihle koku.
Kwaye ukuze sicinge ngaloo nto, ngo-2022, sipapashe iphepha malunga nendlela esebenzayo [00:02:00] yeendlela ezintsha zokuthatha imifanekiso yokuxilonga isifo sikaParkinson eyaqatshelwa njengephepha elinempembelelo kakhulu kwi-MDCP kwikota ka-2021-2022. Ukuba ngandlela ithile sizama ngeli phepha kwaye ngelitsha ndiza kulixelela ngoku ukuba ligubungele uluhlu olupheleleyo lwemifanekiso kwimisebenzi yemihla ngemihla nakuphando, kuba eli phepha lalijolise kakhulu kwiklinikhi.
Yayikukwenza iindlela zokuthatha imifanekiso zisetyenziswe kwimisebenzi yemihla ngemihla kugqirha jikelele, kugqirha jikelele, kwingcali yezifo zengqondo jikelele. Ngoku siyasebenza, kwaye sele sithumele iphepha elihle kakhulu nelibalulekileyo. Ndiyathemba ukulibona lipapashwa kungekudala kwi-Movement Disorders, makhe sibone ukuba lisebenza njani, malunga nee-biomarkers zokuthatha imifanekiso ukuze kuboniswe i-phenoconversion ukusuka kwisifo sikaParkinson esibizwa ngokuba yi-prodromal ukuya kwisifo sikaParkinson esaziwayo ngokwezonyango, nto leyo ebaluleke kakhulu.
Lifikile ixesha elifanelekileyo kwixesha esiphila kulo. Sitshintsha ngandlela thile iingcamango zokuchaza izifo [00:03:00] ngokwezonyango zibe zizifo ezichaza izinto eziphilayo kunye nezifo eziwohlokayo kunye nesifo sikaParkinson. Nangona sinokugxeka ukusetyenziswa kwegama lezinto eziphilayo, silichaza ngokwebhayoloji.
Isifo, kodwa ke ligama elimele amaxesha esiphila kuwo.
Kwaye eli phepha lithetha umsebenzi omninzi kuba sikhangele lonke uncwadi ukukhangela ii-biomarkers zemifanekiso ezithi SPECT, FDG PET, synaptic density PET, kunye nee-MRI biomarkers, i-iron, i-neuromelanin, kunye ne-DTI. Kwaye sizame ukuvavanya ezo mpawu zemifanekiso ngaphakathi kwesakhelo sophando oluhambelanayo, kwaye sizame ukuvavanya nganye kuzo ngaphakathi kwezinye iindawo ekuvunyelwene ngazo kwiqela ngohlobo lwenkqubo efana neDelphi, malunga namandla okuqikelela, malunga nexesha kunye nendlela yokusebenza, malunga nokuqina kunye nokusetyenziswa, kunye malunga nokusetyenziswa kwisakhelo sophando.
Kwakhona, [00:04:00] siwabeke amanqaku la ma-domain ukusuka ku-zero ukuya kwi-4, apho u-zero elona thuba liphantsi okanye ukufumaneka okuphantsi kokufumanisa amandla okuqikelela, kwaye u-4 elona liphezulu. Bekungoko ke umsebenzi omkhulu, kwaye liphepha elihle. Size nolungiselelo olucacileyo lwezi biomarkers, esicinga ukuba luya kuba luncedo kakhulu kuphando nasekuqhubeleni phambili eli candelo.
Ukuqhubela phambili eli candelo ekuphuhliseni unyango oluguqula izifo, ukuqhubela phambili eli candelo ekufumaneni isifo sikaParkinson kunye ne-phenoconversion. Ngoku sinenye iprojekthi ekuza kuphinda into efanayo naleyo siyenzileyo ngenxalenye yokunyakaza, ngenxalenye yokuqonda, nokubona ukuba kuhamba njani ukukhangela zonke iincwadi ezikhangela ii-biomarkers zemifanekiso ukuze kuqikelelwe ukuba i-phenoconversion ibe yi-dementia.
Sisaxoxa ngokuba zeziphi iindidi zabantu ekufuneka zifakwe, nokuba ngabaguli abakhulelweyo kuphela, ukuba kufuneka zifakwe i-MCI, ukuba kufuneka zifakwe kuphela i-PD esele ikho ngaphandle kwe-MCI. Makhe sibone ukuba isebenza njani [00:05:00].
Michele Matarazzo: Ngoko ke ngokuqinisekileyo yayiliqela elifundayo elikhutheleyo kwaye lenze izinto ezininzi. Ngoko ke ndilangazelela ukubona iphepha lipapashwa kwaye, awazi, lisenokuba lelinye inqaku elihle lonyaka kunyaka ozayo, mhlawumbi kuya kufuneka sithethe kwakhona.
Ngoku masiphume kancinci kwiqela lesifundo size sibone ukuba kwenzeka ntoni kwimeko ngokubanzi nebanzi ye-neuroimaging kwicandelo lethu.
Kwenzeke ntoni? Yintoni onokuyigqamisa njengezinto eziphambili zesayensi okanye zeklinikhi ezenzeka kweli candelo kunyaka ophelileyo okanye ngaphezulu?
UCecilia Peralto: Ewe. Enye yeemfuno ezinkulu ezingafezekiswanga kukuphuhliswa kwee-synuclein PET tracers.
Kwaye kukho amaphepha athile apapashweyo. Kwaye izolo besineseshoni entle kwingqungquthela apho uHitoshi Shimada, eveze uphando oluthile kunye nedatha ethile apho kwi-tracer, eyi-18F-CO505, ebonakalise kuphando lwabo ubudlelwane obuphezulu kunye nokubopha kwi-midbrain kunye ne-striatum kwizigulane ze-PD, i-DLB, kunye [00:06:00] kancinci kwizigulane ze-MSA.
Nangona kunjalo, bafumana ukubopha okuthile kwi-amyloid nakwi-tau. Ngoko ke bazama ukuphucula i-molecule nokubona ukuba banokufumana iziphumo ezingcono na. Kodwa luphawu oluthembisayo lwe-alpha-synuclein. Loo nto iyimfuneko kakhulu kwaye inxibelelana kakuhle namaxesha esiphila kuwo into yokutshintsha ukusuka kwi-prodromal ukuya kwi-clinical, kwaye inxibelelana kakuhle nephepha olipapashileyo.
Njengoko ubutshilo ngaphambili, ukwalilungu leqela leNeuroimaging Study Group kwi-multi and co-pathology. Lilicebo elifanelekileyo kakhulu. Lilicebo eliye lavela nakwiinyanga ezimbalwa ezidlulileyo. Liphepha elihle olipapashe nekomiti engaphantsi ezinikele kule miba yesayensi, ukucacisa okuzisa ukukhanya kweli qhinga libalulekileyo kwaye kusenze siqonde ukuba isifo sikaParkinson singaphezulu kwento enye.
Kungaphezulu nje kwe-alpha-synuclein, ukuba kukho ezinye iiproteni ezikhoyo kunye nendlela [00:07:00] ezinokuphazamisa ngayo, masithi, ngandlela thile, kwindlela abaguli abahlakulela ngayo iimpawu kunye nendlela abanokuvelisa ngayo iindlela ezahlukeneyo zokuqhubela phambili kwesifo. Kwaye ngandlela thile oku kwenza ubomi bethu bube nzima ngakumbi.
Kodwa ke, olunye uphawu oluhle lokuba inika ukucaca. Ichaza ezinye izinto ezininzi ezazingaziwa ngaphambili okanye ezazinzima ukuziqonda okanye ukuzichaza kwizigulana. Kwaye ngethemba ukuba lonke olu lwazi luzisa ukukhanya kuphuhliso lwezonyango eziguqula izifo kunye nazo zonke ezi zinto sizifunayo kwizigulana zethu.
UMichele Matarazzo: Kuhle kakhulu. Enkosi ngolu shwankathelo lwento eyenzekileyo. Ngoku siqhele ukuzama ukutshintsha undwendwe esilumemayo minyaka le kule mbalasane yonyaka. Ngoko ke mhlawumbi asizukuba nguwe kunyaka ozayo, kodwa masithi siphinde sidibane nawe kunyaka omnye size sithethe kwakhona ngezinto ezibalulekileyo kwi-neuroimaging.
Yintoni onokuyilindela ukuba yenzeke kunyaka olandelayo oza kuyigxininisa [00:08:00] ngo-2027?
UCecilia Peralto: Ngaphandle-- Andiqinisekanga, kodwa ndingathanda ukubona ukuba kukho inkqubela phambili kwindlela yokudibanisa imifanekiso nophando ukuze kubhalwe iinkqubo zebhayoloji kunye nokufumana amayeza athile okanye ezinye iindlela zokungenelela esinokuziphuhlisa ezinokuphumela okanye ezinokuthi zicothise ukuqhubela phambili kwesifo. Ndicinga ukuba loo nto iya kuba yindlela entle yokudibanisa imifanekiso kwimeko yangoku kwaye sibone indlela ezinokubonakalisa ngayo utshintsho lwe-pathological oluqhubekayo kwaye ngethemba lokuba kukho ezinye iindlela zokungenelela, amayeza, amanye avavanywayo ngoku. Ndibone ezinye izishwankathelo kwingqungquthela umzekelo, nge-prasinezumab. Le datha ibalulekile kakhulu. Ewe, kufuneka iqinisekiswe kwiimvavanyo ezongezelelweyo okanye izifundo ezongezelelweyo, kodwa kubonisiwe ukuba izigulane ezifumana i-prasinezumab kwaye zisebenzisa i-[00:09:00] neuromelanin kunye ne-volumetric kunye ne-ion imaging, kubonisiwe impembelelo ethile yebhayoloji xa kuthelekiswa nezigulane ezifumana i-placebo ngokwazo ezazisebenzisa iyeza eline-neuromelanin, zibonise isandisi esonyukayo xa kuthelekiswa nezigulane ze-placebo ezibonise ukwehla kwesignali.
Kwenzeka into efanayo kwi-ion nakwi-volumetric. Ngoko ke loo nto ndingathanda ukuyibona.
UMichele Matarazzo: Kwaye eneneni, namhlanje nje kuye kwavezwa, uvavanyo lweklinikhi olujolise ekusebenzeni kwe-microglial olusiphumo salo esiphambili yayiyi-neuroinflammatory PET imaging, ngoko ke i-TSPO imaging. Ngoko ke siqala nokubona i-neuroimaging njengesiphumo esiphambili kwintsimi yethu, esele yenzekile kwezinye iinkalo ze-neurology okanye kwane-neurodegeneration kodwa yinto entsha kwihlabathi lethu,
kunene?
UCecilia Peralto: Ewe. Yinyani leyo, kwaye le yindlela eguqukayo, kwaye ndicinga ukuba imifanekiso iza kubuya ngandlela thile kuba asibonanga mifanekiso ingako ngaphandle kweeseshoni ezifanayo okanye [00:10:00] into enjalo kwiingqungquthela zethu. Ngoko ke siza kubona ukubuya komfanekiso njengesiphelo.
Michele Matarazzo: Ngaba kukho nto ibalulekileyo eninayo kwingqungquthela ngokwayo ofuna ukuyabelana ngayo?
UCecilia Peralto: Sibe neeseshoni ezimbini, enye yazo yayiyiseshoni yeklinikhi malunga neendlela ezisebenzayo zokusebenzisa i-MRI kubomi bemihla ngemihla. Oko bekuthandwa kakhulu kwiseshoni ye-neuroimaging. Bekukho abantu ababemi ngasemva, into engaqhelekanga kwiseshoni yemifanekiso.
Oku sikubona kwezinye iintlobo, kodwa kungekhona kwimifanekiso. Kwaye izolo, besineseshoni yesayensi ejolise ekucingeni ngokusetyenziswa kwe-neuroimaging ngo-2026. Yintoni elandelayo? Ngawaphi amanyathelo alandelayo? Kwaye loo seshoni yayiquka isihloko sendlela yokusebenzisa iimpawu zemifanekiso ukuchonga i-phenoconversion, ii-PET synuclein tracers, kunye nengcamango ye-imaging co-pathology.
Loo nto ibe luncedo kakhulu kwaye yayintle kakhulu. Ndingathanda ukugqamisa oku. [00:11:00] Nezinye izinto... kukho ezinye izishwankathelo. Kukho izishwankathelo ezininzi ezibalulekileyo. Ndingakhankanya enye endichukumisileyo okanye eyatsala ingqalelo yam. Ndiyakhumbula kwi-florbetapir tau PET ebonisa ukuba izigulane ze-PD ezine-RBD zibonakalise ukufunxwa okukhulu xa kuthelekiswa nezigulane ezingenalo ulwazi olubi kwaye ezingenayo i-RBD kwi-striatum, kwi-insula.
Kwaye leyo yindlela elungileyo yokubonisa indlela izigulane ezineengxaki zokuqonda eziye zanda ngayo i-tau binding xa kuthelekiswa nezo zingenayo. Ngoko ke kukho izinto endinokuzigqamisa.
Michele Matarazzo: Ugqibelele. Cecilia, enkosi kakhulu ngokundijoyina namhlanje. Zininzi izinto ezenzekayo kweli candelo, ingakumbi umsebenzi omninzi owenziwe yiNeuroimaging Study Group, enceda ekuqhubeleni phambili eli candelo. Qhubeka nomsebenzi omhle.
Enkosi kakhulu, Cecilia, kwaye ndiyanibulela nonke ngokumamela.
Cecilia Peralto: Enkosi kakhulu ngexesha lakho. [00:12:00]
![]()
UCecilia Peralta, MD
Isibhedlele seYunivesithi iCEMIC
EBuenos Aires, eArgentina






